4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029614
Chief Operating Officer sold 1,591 shares at $25.85 ($41,127)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-03-07 | Sale 10b5-1 | −1,591 | $25.85 | $41,127 | 186,291 | D |
| Open-market sales · 1,591 sh · avg $25.85 · $41,127 | |||||||
Loading xslF345X05/ownership.xml…